Drug profile · INN
piroxicam
APO-PIROXICAM
piroxicam (APO-PIROXICAM) is a cyclooxygenase inhibitor. Associated with Apotex Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — piroxicam
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
piroxicam (APO-PIROXICAM) is a cyclooxygenase inhibitor. Associated with Apotex Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is piroxicam?
piroxicam (APO-PIROXICAM) is a cyclooxygenase inhibitor. Associated with Apotex Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for piroxicam?
APO-PIROXICAM is a marketed brand name for piroxicam. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of piroxicam?
piroxicam has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.